Advancing AAV technology: From capsid design to scalable manufacturing.
作者信息
Stone Daniel, Mietzsch Mario, Ronzitti Giuseppe
机构信息
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA.
出版信息
Mol Ther Methods Clin Dev. 2025 May 7;33(2):101477. doi: 10.1016/j.omtm.2025.101477. eCollection 2025 Jun 12.
Abstract
摘要
相似文献
1
Advancing AAV technology: From capsid design to scalable manufacturing.
Mol Ther Methods Clin Dev. 2025 May 7;33(2):101477. doi: 10.1016/j.omtm.2025.101477. eCollection 2025 Jun 12.
2
Membrane chromatography for AAV full capsid enrichment: Process development to scale up.
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Aug 15;1244:124258. doi: 10.1016/j.jchromb.2024.124258. Epub 2024 Jul 25.
3
A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency.
Mol Ther Methods Clin Dev. 2024 Mar 4;32(2):101228. doi: 10.1016/j.omtm.2024.101228. eCollection 2024 Jun 13.
4
Production, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors.
Biotechnol J. 2021 Jan;16(1):e2000025. doi: 10.1002/biot.202000025. Epub 2020 Oct 7.
5
IsoTagAAV: an innovative, scalable & non-chromatographic method for streamlined AAV manufacturing.
Cell Gene Ther Insights. 2022 Nov;8(10):1287-1300. doi: 10.18609/cgti.2022.190. Epub 2022 Nov 3.
6
Rational downstream development for adeno-associated virus full/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling.
J Chromatogr A. 2024 Feb 8;1716:464632. doi: 10.1016/j.chroma.2024.464632. Epub 2024 Jan 9.
7
The role of the adeno-associated virus capsid in gene transfer.
Methods Mol Biol. 2008;437:51-91. doi: 10.1007/978-1-59745-210-6_2.
8
Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
Expert Opin Biol Ther. 2021 Jun;21(6):749-766. doi: 10.1080/14712598.2021.1865303. Epub 2020 Dec 30.
9
A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes.
Mol Ther Methods Clin Dev. 2023 May 8;29:426-436. doi: 10.1016/j.omtm.2023.05.004. eCollection 2023 Jun 8.
10
Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
Hum Gene Ther. 2010 Oct;21(10):1259-71. doi: 10.1089/hum.2010.055.
本文引用的文献
1
AAV capsids target muscle-resident cells with different efficiencies-A comparative study between AAV8, AAVMYO, and AAVMYO2.
Mol Ther Methods Clin Dev. 2025 Mar 14;33(2):101451. doi: 10.1016/j.omtm.2025.101451. eCollection 2025 Jun 12.
2
A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors.
Mol Ther Methods Clin Dev. 2025 Mar 3;33(2):101441. doi: 10.1016/j.omtm.2025.101441. eCollection 2025 Jun 12.
3
AAV vector development, back to the future.
Mol Ther. 2025 May 7;33(5):1903-1936. doi: 10.1016/j.ymthe.2025.03.064. Epub 2025 Apr 3.
4
Advances in AAV capsid engineering: Integrating rational design, directed evolution and machine learning.
Mol Ther. 2025 May 7;33(5):1937-1945. doi: 10.1016/j.ymthe.2025.03.056. Epub 2025 Apr 1.
5
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution.
Mol Ther Methods Clin Dev. 2025 Jan 22;33(1):101417. doi: 10.1016/j.omtm.2025.101417. eCollection 2025 Mar 13.
6
Identification of the role of SNARE proteins in rAAV vector production through interaction with the viral MAAP.
Mol Ther Methods Clin Dev. 2024 Dec 5;33(1):101392. doi: 10.1016/j.omtm.2024.101392. eCollection 2025 Mar 13.
7
αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues.
Mol Ther Methods Clin Dev. 2024 Nov 12;32(4):101378. doi: 10.1016/j.omtm.2024.101378. eCollection 2024 Dec 12.
8
Quantitative proteomic analysis of residual host cell protein retention across adeno-associated virus affinity chromatography.
Mol Ther Methods Clin Dev. 2024 Nov 18;32(4):101383. doi: 10.1016/j.omtm.2024.101383. eCollection 2024 Dec 12.
9
Structural characterization and epitope mapping of the AAVX affinity purification ligand.
Mol Ther Methods Clin Dev. 2024 Nov 12;32(4):101377. doi: 10.1016/j.omtm.2024.101377. eCollection 2024 Dec 12.
10
Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness.
Mol Ther Methods Clin Dev. 2024 Aug 20;32(3):101327. doi: 10.1016/j.omtm.2024.101327. eCollection 2024 Sep 12.
Zotero 插件